Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of the Efficacy and Safety of a Medical Device in the Form of Rectal Suppositories (Prospidol®) for the Treatment of Symptoms Associated With Chronic Prostatitis/Chronic Pelvic Pain Syndrome.

NCT07685847 is registered in ClinicalTrials.gov with S&R Farmaceutici S.p.A. as lead sponsor.

NCT NCT07685847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07685847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of the Efficacy and Safety of a Medical Device in the Form of Rectal Suppositories (Prospidol®) for the Treatment of Symptoms Associated With Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Lead sponsor
S&R Farmaceutici S.p.A.
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2025
Completion date
July 28, 2026
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic prostatitis/chronic pelvic pain syndrome (cp/cpps)